NCT02339025View on ClinicalTrials.gov

DoD-NCI TRICARE Feasibility Study

CompletedOBSERVATIONAL

Enrollment

93

Participants

Timeline

Start Date

August 18, 2018

Primary Completion Date

September 23, 2019

Study Completion Date

September 23, 2019

Conditions

Cancer

Trial Locations (1)

20301

Walter Reed National Medical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT02339025 - DoD-NCI TRICARE Feasibility Study | Biotech Hunter | Biotech Hunter